Novozymes CFO: Powerful momentum in bioenergy division

Comprehensively, we are seeing a powerful momentum in the division, says the company's chief financial officer.

Bioenergy sales, which for Novozymes consists of enzyme sales for bioethanol production, showed an organic growth rate of 5 percent in the fourth quarter of 2018.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading